chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever of 100.2 F after booster; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 100.2 F after booster) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 052E21A, 039B21A and 006B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (Fever of 100.2 F after booster). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Fever, at a dose of 1 dosage form. At the time of the report, PYREXIA (Fever of 100.2 F after booster) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Nov-2021, Body temperature: 100.2 f (High) Fever of 100.2 F and 99.0 f (Low) patient took a Tylenol about 20 minutes ago and his temperature is  99.0 F..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication was reported. Treatment medication reported also included Hydrate for fever.  The doctor told the patient to take 2 Tylenol and hydrate and advised them that if the temperature goes above 100.4 then get in touch with MD. Reportedly, the patient stated that they took a Tylenol about 20 minutes ago and their temperature was now 99.0 F.   This case was linked to MOD-2021-375574, MOD-2021-375559 (Patient Link).
After 4th immune given, right leg recovered, baby became limp, remained responsive, stopped crying, then when baby was picked up she became more alert, body tone returned to pre-immuniz way
Information has been received from a RN concerning a 45 year old female employee with no known drug allergies and no known food allergies who on 2/22/03 was vaccinated with a first dose of hep B vaccine (644388/1018M) SC in the right deltoid. Subsequently, thirty minutes later the pt developed itching on upper chest and both arms, light diffuse rash, lips tingling, face flushed, lips slightly swollen and a mild headache. The pt was treated with epinephrine (.4cc) SC, prednisone (60mg) po, and Benadryl (50mg) IM. The pt was not hospitalized. It was reported that the pt recovered. Additional info has been requested.
Vaccine was given at 4:10pm on Wednesday, March 31. My side effects didn't begin until 46 hours after receiving vaccine. Fever of 101 began at 2pm on Friday, April 2 and lasted about 12 hours. The following day no fever but my arm was suddenly sore and achy (it had not been achy at all before), I had a headache and felt wiped out. These symptoms lasted untill about 6pm on Saturday, April 3. Completely recovered by the evening.
Body aches; Fluctuation in his  temperature; Extremely thirsty; Severe weakness; Diarrhea; Stiff neck; Bone pain feels worse than when he had covid; Fever; Nausea; Muscle pain feels worse than when he has covid; A spontaneous report was received from a nurse reporting on behalf of himself, a 50-year-old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced body aches, fluctuation in his temperature, fever, extremely thirst, severe weakness, nausea, diarrhea, stiff neck, muscle pain and bone pain.   The patient's medical history included COVID-19 infection. Concomitant product use was not provided by the reporter.   On 22 Dec 2020, approximately one day prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.   On 23 Dec 2020, in the early morning, the patient experienced body aches, fluctuation in his temperature, fever, extreme thirst, severe weakness, nausea, diarrhea and a stiff neck. Additionally, the patient reported experiencing muscle and bone pain that felt worse than when he had COVID-19. Treatment for the event included ondansetron for nausea and acetaminophen for his stiff neck.   Action taken with mRNA-1273 in response to the events was not provided.   The outcome for the events, body aches, fluctuation in his temperature, fever, extremely thirst, severe weakness, nausea, diarrhea, stiff neck, muscle pain and bone pain, was not reported.; Reporter's Comments: This case concerns a 50-year-old  male patient with a medical history of COVID-19, who received their first of two planned doses of mRNA-1273 (Lot unknown), and who experienced the listed events of diarrhea, fever, nausea, and muscle pain, and the unlisted events of body aches, fluctuation in temperature, fever, thirst, weakness, stiff neck, and bone pain.  The events were considered possibly related to the vaccine due to the temporal relationship with onset of events the day after the first dose.
PATIENT RECEIVED INFLUENZA VACCINE 11/10/2022.  ANOTHER DOSE WAS DOCUMENTED AS RECEIVED ON 09/15/2022 BY ANOTHER FACILITY.
5MAR pt recv vax & woke up 16MAR96 w/rash (red) to upper body & t103;17MAR t100;18MAR no temp;dx probable measles,severe OM bilat
I have a small little, it's not even a cut, it's like a little dot on my arm and everyday I take the band aid off and it bleeds; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiration date were not reported) via an unspecified route of administration, administered in arm on an unspecified date on 2021 as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient reported, a reaction to Pfizer covid vaccine to get on an unspecified date on 2021. On an unspecified date on 2021, the patient had experienced I have a small little, it's not even a cut, it's like a little dot on my arm and everyday I take the band aid off and it bleeds. The outcome of the event was unknown.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
The medical history included herpes virus NOS infection and Lyme disease (1996). She had no adverse experiences following receipt of prior unspecified immunizations. There were no concurrent medications. In 1999, the pt reportedly received her 1st and 2nd injections of Lymerix; exact dates of immunization were no recalled by the pt. In 1/00 or 2/00, she experienced "an episode of paralysis" which she described as "I suddenly stiffened up and couldn't move". She stated that the episode "lasted only briefly". She reported the episode to her physician in 4/00 or 5/00, when she received her 3rd dose of Lymerix. "Soon after" receiving the 3rd injection of Lymerix, she reportedly began to experience pain in her back and feet "that makes walking hard" and numbness in her arms. She returned to her family physician who referred her to a rheumatologist. The rheumatologist reportedly made a dx of arthritis. Treatment included "steroids and pain killers". The arthritis persisted as of 6/7/02. The adverse events "arthritis" and "paralysis" do not meet serious criteria.
pt returned to center 10JUN05 for laceration recheck & stated that on 8JUn & 9JUN lt arm was red & swollen from shoulder to hand; 10JUN95 noted @ site of inj .5cm area red, non-raised; no other swelling noted;
Patient was seen in our office due to right deltoid red, swollen. Patient was rx KEFLEX 250mg, twice a day for 10 days.
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions, drug reactions, allergies or concomitant medications. On 18-JUL-2018, the patient was vaccinated with an improperly stored dose of VARIVAX for prophylaxis (strength, dose number, anatomical location, route of administration were not reported). There was unknown if the patient received the lot No N031001 (Exp date 03-NOV-2019), lot No N034557 (Exp date 05-DEC-2019) or lot No N034553 (Exp date 05-DEC-2019). The VARIVAX was reconstituted with a properly stored sterile diluent and there was not adverse effect reported. The temperature was from 6 degrees Fahrenheit (°F) to 14°F for a time frame of 35 minutes without previous temperature excursions and was called because a digital data logger. This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1807USA011606: US-009507513-1807USA012253: US-009507513-1807USA012256: US-009507513-1807USA012264: US-009507513-1807USA012258: US-009507513-1807USA012259: US-009507513-1807USA012260: US-009507513-1807USA012261: US-009507513-1807USA012262: US-009507513-1807USA012263: US-009507513-1807USA012254: US-009507513-1807USA012257:
Patient came in to tell me that she was diagnosed with shingles by a physician 10 days after she got the shingles shot. She said that she also had shingles after the Zostavax shot.  She had all of the symptoms that accompany shingles, including rash, tingling and itching.
Mild rash on arm and chest. Treatment includes self treatment with oral antihistamine. Course unknown.
tachycardia causing atrial fibrillation treated with dilatiazem 60 mg duration 7 hours
R upper arm swollen, painful, red and warm to touch. Advised OTC BENADRYL and TYLENOL PRN.
Tinnitus,  came on as fever and other regular reaction symptoms started.  As of mid sunday morning other symptom have resolved tinnitus has not
ED visit, Non-prescription medication, Prescription medication Anaphylaxis Received this first dose at theme park . PMHx of POTS syndrome who presents to the ED with c/o allergic reaction. Patient reports she received her first COVID vaccination dose earlier today (Pfizer) and about 20 minutes after her vaccine, she developed a flushed face with heart palpitations, chest tightness and shortness of breath. After EMS arrival, she received 0.3mg epinephrine with 50mg Benadryl with improvement in her symptoms. She otherwise denies any fevers, cough or nausea, vomiting or diarrhea. EKG 12 lead; also received Famotidine 20 mg injection/oral, Prednisone 20 mg, Solu-medrol
Pt developed shoulder and arm pain requiring X-rays and treatment with 800mg ibuprofen.
I had a lot of pain where the vaccine was given initially, but thought it was not a big deal. It seemed to go away after a few days, but today (a week after vaccination) for some reason, it's back, and I noticed the spot around where I was vaccinated has grown to the size of a golf ball.
Information has been received from a medical assistant concerning a 5 year old male patient who on an unspecified date was vaccinated with VARIVAX (Merck). It was reported that the patient received 2 doses of VARIVAX (Merck) and he had breakthrough of varicella after receiving the last dose. Lot number not available. The patient's sought medical attention, he went to clinic. At the time of reporting the patient's outcome was unknown. A phone call was received from a woman in a physician's office stating that they did not have any further information to provide regarding this adverse experience. Additional information is not expected.
Patient c/o redness at site of injection (Left deltoid) tenderness to touch and off and on fever. Required a doctors visit to assess the injection site. There was no need to go to the hospital. Patient recovered.
A non-serious spontaneous report "middle and index finger cuts" was received from a nurse concerning an adult female, subsequent to FLUMIST administration.  Neither medical history nor concomitant medications have been reported.  The reporter administered FLUMIST to another person.  As she was placing the syringe into the sharps container, she noticed blood on her hand.  After removing her glove, she found two small but deep cuts on her middle and index fingers that were bleeding.  She inspected the glove and noted three small puncture marks.  She then inspected the syringe and noticed that the finger flange was chipped.  She stated that the only way she could see this happening was due to the product packaging somehow being compressed or jostled enough to cause pressure during transport.  She was not sure if she did any compressing or jostling on the packages either.  The outcome of the event is unknown.
6/4/13 Pt. received Tdap. 6/6 Pt. called clinic c/o swelling, redness and warmth at site. Advised to apply ice, take Ibuprofen and antihistamine. 6/7 seen in clinic, 5x5 cm area at site w/edema and warmth and itchinss. No pain, good ROM. No sx of cellulitis per Dr.
Patient had a swollen left toes after 2 days with unbearable pain. Pt went to ER and had all tests came negative. The swelling and pain went away next day.
swelling, induration, redness- was seen in ER on 10/11/2023
Beginning approximately 12 hours after vaccination: Uncontrollable chills for 1 hour  Fever of 103°F for 10 hours not relieved with analgesics   Headache  for 18-24 hours  Fatigue for 24 hours
Day 1: Pt had flu like symptoms to include nausea, headache, body aches. Day 2: Pt still had body aches which were controlled with OTC ALEVE. Day4-5: Pt started to develop hives on her right wrist and inner elbow, redness on right elbow, hive on left inner wrist, few hives on back and 1 hive on the middle of the shin of the left leg.
Pain in left arm, shoulder, neck and down neck. Began two days severely after shot called doctor on 4th and 5th day and saw doctor 8 days later. Physical therapy, pain relievers. Starting treatment.
Humaria stopped working and became immune; arm to swell with a giant ball; Humaria stopped working and became immune; Liver function test increased; This spontaneous case was reported by a consumer and describes the occurrence of LIVER FUNCTION TEST INCREASED (Liver function test increased), DRUG TOLERANCE INCREASED (Humaria stopped working and became immune), PERIPHERAL SWELLING (arm to swell with a giant ball) and THERAPEUTIC PRODUCT EFFECT DECREASED (Humaria stopped working and became immune) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) injection for Plaque psoriasis.    There was no reported medical history.  Concurrent medical conditions included Plaque psoriasis.   On 16-Jun-2020, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In November 2021, ADALIMUMAB (HUMIRA) (Subcutaneous) dosage was changed to at an unspecified dose. In August 2021, the patient experienced LIVER FUNCTION TEST INCREASED (Liver function test increased). On an unknown date, the patient experienced DRUG TOLERANCE INCREASED (Humaria stopped working and became immune), PERIPHERAL SWELLING (arm to swell with a giant ball) and THERAPEUTIC PRODUCT EFFECT DECREASED (Humaria stopped working and became immune). At the time of the report, LIVER FUNCTION TEST INCREASED (Liver function test increased), DRUG TOLERANCE INCREASED (Humaria stopped working and became immune) and THERAPEUTIC PRODUCT EFFECT DECREASED (Humaria stopped working and became immune) had not resolved and PERIPHERAL SWELLING (arm to swell with a giant ball) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In August 2021, Liver function test: increased increased.         Concomitant drugs were not reported. No treatment medication information reported.
Patient had joint and muscle weakness within a few hours of receiving vaccine. He stated his joints felt like they were on fire. By the evening he was running a fever and had difficulty walking and standing. He also had nausea and vomiting. Symptoms resolved within approximately 24 hours from time they started.
Large annular rash with central induration, increased warmth, tenderness and pruritus. Subjective chills. Treated with ice pack, MOTRIN and TYLENOL #3 (codeine).
UTI; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that: a female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: Unknown) via an unspecified route of administration on 01Apr2021 as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included bnt162b2 bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: Unknown) via an unspecified route of administration on 11Mar2021 as dose 1, single for covid-19 immunisation. On an unspecified date Apr2021, the patient was diagnosed with UTI (urinary tract infection) and she was prescribed with antibiotics. She wanted to know if the medication would interfere with the vaccine. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
sx: dizziness, headache, chills, scratchy throat at 11:45am. started to have rash at 11:55am. BP checked q 15 min since sx started with readings of 120/80, 118/80, 110/83 mmHg. patient drank sprite and was given 2 tablets of diphenhydramine 15 mg by mouth. At 12:11PM rash resolved and sx slowly disappearing. Patient left at 12:22PM with little headache.
Temperature; No appetite; Weakness; Chills; Headache; Nausea; This spontaneous case was reported by a nurse and describes the occurrence of BODY TEMPERATURE INCREASED (Temperature), DECREASED APPETITE (No appetite), ASTHENIA (Weakness), CHILLS (Chills) and HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 20-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, the patient experienced BODY TEMPERATURE INCREASED (Temperature), DECREASED APPETITE (No appetite), ASTHENIA (Weakness), CHILLS (Chills), HEADACHE (Headache) and NAUSEA (Nausea). At the time of the report, BODY TEMPERATURE INCREASED (Temperature), DECREASED APPETITE (No appetite), ASTHENIA (Weakness), CHILLS (Chills), HEADACHE (Headache) and NAUSEA (Nausea) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator o No treatment medications provided by the reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Meningococcal B vaccine inadvertently administered to age younger than 16 in a  healthy child
I received the 1st shot of the pfizer covid vaccine on March 11, 2021. Within 2 days I began to feel extremely fatigued. The days following I experienced night sweats, nausea, extreme fatigue, fever. I went to urgent care with a 102 fever, jaundice, and anemia. Urgent care sent me to the ER. At the ER they admitted me to the hospital. I was in the hospital for 3 days with hemolytic anemia. After a lot of testing and ruling out any infections, they discovered I have a rare blood disorder: hereditary elliptocytosis. The pfizer vaccine created an immune response and since I have this blood disorder I was predisposed to this event occurring from the vaccine (hemolytic anemia/juandice) without knowing it. It was a result of the vaccine. I was told to not get the second shot because there is no guidance, but that I am a high risk individual now. I need medical advice from people who are familiar and know.
Complain of rash on legs, stomach, and under arms. Small red bumps. itchy. Lump and pain at injection site.
Third dose  24Sep2021; expired dose; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Third dose  24Sep2021) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Mar-2021, the patient received twelfth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired dose). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Third dose  24Sep2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Third dose  24Sep2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was mentioned. No treatment medication was mentioned.
Pain started by the injection site about a week after and has continued to get worse.  I am also having pain in my chest muscle on the left side.  My left arm where I received the both doses is weaker then my right arm.
Spotty on left front chest and back. Pt mentioned some pain as well as itch.
Pt received vaccines and about 15 minutes later she was walking out and passed out. While falling pt hit desk with her mouth and chipped her tooth.
Patient received TDAP (Boostrix) vaccine on 01/10/2022 and reported feeling muscle aches, severe chills, low grade fever, and headaches after vaccine. No visit to clinic or urgent care. Patient proceeded to take COVID test on 01/12/2022 and received negative results 01/14/2022. Patient reports to be asymptomatic on 01/14/2022. Per Tdap vaccine information sheet given to patient the day of vaccination on 01/10/2022 it was advised reaction was possible even though it was uncommon. Per patient's PCP no need for further testing or medications.
Covid-19 Lot FE3590 Vial PAA165969 Exp 2/22 was placed in the freezer after we received it. It should have been pulled out of the freezer on 10/19/21 at 12:00pm according to the storage guidelines and placed in the refrigerator for 31 days,  Our staff did not pull the vial out of the freezer on this date.  The staff noticed the date this morning, November 2, 2021 at 0830.   There were 22 patients who received the COVID vaccination during this time frame. The vials were pulled out of the freezer, thawed, and diluted per Instructions during 10/19/21 through November 1,  2021. There are 27 vials that were not used and have been set aside to waste.
classic shingle (Zoster of dermatone) of left T 8-9 dermatone.
Patient reported an "itchy throat" described as a "mild reaction".   Remained under observation for additional time, no intervention or additional treatment provided.
Patient received the vaccine but she is under age. Vaccine approved for 16+ and patient was only 15 at the time of vaccination.  No other adverse reactions have been reported